Table 1 Baseline characteristics of the CDCS cohort
Baseline characteristics | n | Mean ± SE or n (%) |
|---|---|---|
Male Gender | 2067 | 1483 (71.7%) |
Index event diagnosis: | ||
 Unstable Angina | 2067 | 553 (26.8%) |
 ST-elevation MI | 2067 | 460 (22.2%) |
 Non-ST-elevation MI | 2067 | 1054 (51.0%) |
Age at baseline (years) | 2067 | 66.6 ± 0.27 |
Ethnicity (European, Maori & Pasifika, Other, Unknown) | 2067 | 85.9,4.8,3.0,6.3% |
Previous MI | 2053 | 619 (30.2%) |
Antecedent Hypertension | 2050 | 1069 (52.1%) |
Type II diabetes | 2061 | 336 (16.3%) |
Renal disease | 2052 | 205 (10.0%) |
BMI (kg/m2) | 2039 | 27.6 ± 0.11 |
Tobacco Use (never smoked) | 2067 | 750 (36.3%) |
Alcohol Use (non-drinker) | 2064 | 516 (25.0%) |
LVEF | 1967 | 57.3% ± 0.27 |
Discharge Medications | ||
 ACE inhibitor | 2067 | 1178(57.0%) |
 β-blocker | 2067 | 1778 (86.0%) |
 Diuretic | 2067 | 566 (27.4%) |
 Statin | 2067 | 1826 (88.3%) |